Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle Proteins | 6 | 2014 | 117 | 1.110 |
Why?
|
| DNA-Binding Proteins | 8 | 2014 | 1182 | 0.870 |
Why?
|
| Transcription Factors | 7 | 2014 | 1512 | 0.710 |
Why?
|
| Endothelial Cells | 6 | 2014 | 185 | 0.670 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2011 | 16 | 0.520 |
Why?
|
| GTP-Binding Proteins | 3 | 2011 | 82 | 0.500 |
Why?
|
| Neovascularization, Physiologic | 3 | 2014 | 104 | 0.430 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2012 | 6 | 0.400 |
Why?
|
| Energy Metabolism | 1 | 2015 | 379 | 0.390 |
Why?
|
| Interferon-gamma | 3 | 2011 | 568 | 0.380 |
Why?
|
| Microvessels | 1 | 2012 | 19 | 0.380 |
Why?
|
| Vasodilation | 1 | 2012 | 36 | 0.380 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2010 | 19 | 0.360 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 175 | 0.350 |
Why?
|
| Fibronectins | 1 | 2010 | 43 | 0.330 |
Why?
|
| Neovascularization, Pathologic | 2 | 2011 | 140 | 0.320 |
Why?
|
| Blood Glucose | 1 | 2012 | 483 | 0.320 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 171 | 0.320 |
Why?
|
| Cell Movement | 2 | 2014 | 450 | 0.310 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2009 | 77 | 0.310 |
Why?
|
| Hypoxia | 1 | 2009 | 115 | 0.300 |
Why?
|
| Exercise | 1 | 2015 | 939 | 0.290 |
Why?
|
| Transcription Factor RelA | 2 | 2013 | 50 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 3 | 2013 | 674 | 0.180 |
Why?
|
| Transcription, Genetic | 4 | 2013 | 877 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 613 | 0.160 |
Why?
|
| Neoplasms | 1 | 2009 | 1351 | 0.150 |
Why?
|
| HEK293 Cells | 4 | 2014 | 617 | 0.150 |
Why?
|
| Fibroblasts | 2 | 2011 | 391 | 0.150 |
Why?
|
| Homeostasis | 2 | 2012 | 369 | 0.150 |
Why?
|
| Animals | 11 | 2014 | 20659 | 0.150 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 908 | 0.120 |
Why?
|
| Cattle | 2 | 2014 | 309 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2013 | 34 | 0.110 |
Why?
|
| Mice | 7 | 2014 | 10847 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 209 | 0.110 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2014 | 1 | 0.110 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2014 | 39 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2014 | 983 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2014 | 2156 | 0.110 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 79 | 0.100 |
Why?
|
| Computational Biology | 1 | 2015 | 354 | 0.100 |
Why?
|
| Amino Acid Substitution | 2 | 2010 | 240 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2014 | 3033 | 0.100 |
Why?
|
| Humans | 12 | 2015 | 62959 | 0.100 |
Why?
|
| Connexins | 1 | 2012 | 9 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Hearing | 1 | 2012 | 34 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 22 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 336 | 0.090 |
Why?
|
| Cell Communication | 1 | 2012 | 131 | 0.090 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 90 | 0.090 |
Why?
|
| Protein Prenylation | 1 | 2010 | 7 | 0.090 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 60 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2011 | 82 | 0.090 |
Why?
|
| Receptors, Fibronectin | 1 | 2010 | 1 | 0.090 |
Why?
|
| Integrin alpha4 | 1 | 2010 | 4 | 0.090 |
Why?
|
| Guanosine Triphosphate | 1 | 2010 | 50 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2009 | 9 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2010 | 207 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2010 | 381 | 0.080 |
Why?
|
| Ischemia | 1 | 2011 | 204 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 777 | 0.080 |
Why?
|
| Cell Line | 2 | 2011 | 2036 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 203 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2012 | 411 | 0.080 |
Why?
|
| Apoptosis | 1 | 2014 | 1073 | 0.070 |
Why?
|
| Antiviral Agents | 1 | 2011 | 322 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 212 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2011 | 623 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2012 | 2109 | 0.070 |
Why?
|
| Melanoma | 1 | 2010 | 331 | 0.060 |
Why?
|
| Obesity | 1 | 2012 | 1232 | 0.060 |
Why?
|
| Cell Aggregation | 2 | 2014 | 21 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2011 | 833 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2013 | 186 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 1615 | 0.040 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2014 | 1 | 0.030 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2014 | 5 | 0.030 |
Why?
|
| Chromones | 1 | 2014 | 19 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 2014 | 14 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 14 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 88 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2014 | 109 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2013 | 174 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 247 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 542 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 611 | 0.020 |
Why?
|
| Connexin 43 | 1 | 2012 | 13 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 220 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 863 | 0.020 |
Why?
|
| Blood Circulation | 1 | 2011 | 8 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2011 | 27 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 45 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 17 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 42 | 0.020 |
Why?
|
| I-kappa B Proteins | 1 | 2011 | 39 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 903 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 99 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2011 | 48 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 113 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 838 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2010 | 110 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 101 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2011 | 96 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 618 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 1595 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1997 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 260 | 0.020 |
Why?
|
| Protein Binding | 1 | 2013 | 1607 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 670 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 1333 | 0.020 |
Why?
|